Posted on 11/24/20
Quest Diagnostics Earns Gold Status in American Heart Association's 2020 Workplace Health Achievement Index
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2020 . . .
Posted on 11/24/20
Elevian Closes $15 Million Equity Financing
Elevian, an emerging biotech company developing medicines that restore youthful regenerative capacity with the potential to treat and prevent multiple age-related diseases, today announced the closing . . .
Posted on 11/24/20
RRD International Acquired By Uniphar
RRD International, a specialized product development company that provides strategic and operational support to biopharmaceutical companies and investors, announced today it has been acquired by Uniphar . . .
Posted on 11/24/20
Advaxis Prices of $8 Million Public Offering
PRINCETON, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today . . .
Posted on 11/24/20
OpGen Prices $10 Million Private Placement
GAITHERSBURG, Md., Nov. 24, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help . . .
Posted on 11/24/20
Virginia Sees Significant Uptick in COVID-19 Cases, Deaths
As the coronavirus spreads dramatically across the nation, Virginia recorded 16,401 new COVID-19 cases and 136 deaths last week, a significant increase in both statistics compared . . .
Posted on 11/24/20
Sorrento Therapeutics' Multifaceted Plan to Attack COVID-19
Sorrento Therapeutics(NASDAQ:SRNE) arguably has the most diverse set of products for the COVID-19 pandemic. In this video from Motley Fool Live recorded on Nov. 12, executives . . .
Posted on 11/24/20
What Should Sorrento Therapeutics' Investors Look for in the Months Ahead?
In this video from Motley Fool Live recorded on Nov. 12, Henry Ji, chairman, president, and CEO of Sorrento Therapeutics(NASDAQ:SRNE), highlights what investors should expect from . . .
Posted on 11/24/20
Better Buy: Gilead Sciences vs. Pfizer
Two healthcare giants have been at the forefront in the fight against COVID-19. Gilead Sciences (NASDAQ:GILD) was among the first companies to win FDA emergency use . . .
Posted on 11/24/20
Select Medical Holdings Corp.: Breakout Underway
SummarySince its earnings report, it has broken out from the healthcare sector in the broad market.Trading above its 50- and 200-day averages.Issued guidance that full-year results . . .
Posted on 11/24/20
Maryland’s Average Positive Test Rate Remains Above 5% for 15 Straight Days
Maryland’s average rate of coronavirus tests coming back positive over the last seven days is 6.88%, and that average has remained above 5% for 15 straight . . .
Posted on 11/24/20
Advaxis Announces Proposed Public Offering of Common Stock
PRINCETON, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today . . .
Posted on 11/23/20
Qiagen: Strong Short-Term COVID Play
Summary Qiagen has been a beneficiary of COVID related tailwinds particularly as related to COVID testing, which has driven strong revenue growth and profitability.Several new products . . .
Posted on 11/23/20
Hospice Source Acquires Superior Healthcare
Hospice Source, a leading provider of durable medical equipment dedicated to the hospice market, acquired Superior Healthcare, Inc. of Martinez, California. The acquisition furthers Hospice Source's . . .
Posted on 11/23/20
ATAI Life Sciences Closes $125 Million Series C Financing
ATAI Life Sciences, a global biotech company developing psychedelic and non-psychedelic compounds for various mental health indications, today announced the successful closing of its $125 million . . .
Posted on 11/23/20
Rosedale Federal Donates $100K to Support UM St. Joseph Patient Experience
To celebrate the redesign of its newest branch location in Towson, Rosedale Federal Savings & Loan Association, a locally run, independent mutual savings and loan institution . . .
Posted on 11/23/20
Baudax Bio Offers $12 Million Common Stock
MALVERN, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that it . . .
Posted on 11/23/20
COVID Collaborative Announces Partnership with Ad Council on $50 Million Vaccine Education Campaign
Today, COVID Collaborative announced a partnership with the Ad Council on an unprecedented $50 million vaccine education campaign. This initiative will represent one of the largest . . .
Posted on 11/23/20
BioLineRx Reports Third Quarter 2020 Financial Results and Provides Corporate Update
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended September 30, 2020 . . .
Posted on 11/23/20
Ad Council Launches $50 Million Fund for National COVID-19 Vaccine Education Effort
The Ad Council today announced plans for a communications effort to encourage vaccination against the virus, which will represent one of the largest public education campaigns . . .
Posted on 11/23/20
Catamaran Bio Launches with $42 Million Financing
Catamaran Bio, Inc., a biotechnology company developing allogeneic CAR-NK cell therapies to treat cancer, today announced that the company has launched with $42 million in financing.
Posted on 11/23/20
Merck To Acquire OncoImmune For $425M
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and OncoImmune, a privately-held, clinical-stage biopharmaceutical company
Posted on 11/23/20
Better Coronavirus Stock: Moderna or Novavax?
Does big pharma dominate the coronavirus vaccine race? It might seem that way. Of the five COVID-19 vaccine candidates in late-stage testing that could be players . . .
Posted on 11/23/20
Here's Why Moderna's Coronavirus Vaccine Could Outsell Pfizer's
If you could get a coronavirus inoculation this afternoon, you probably wouldn't care if the clinician told you that the shot might feel a bit chilly. . . .
Posted on 11/23/20
How Do Pfizer's and Moderna's COVID Vaccine Results Compare?
We've now heard interim results for two of the leading coronavirus vaccine candidates. Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) announced initial data for their experimental COVID-19 vaccine BNT162b2 on . . .

